Fenfluramine-induced gene dysregulation in human pulmonary artery smooth muscle and endothelial cells

Fenfluramine is prescribed either alone or in combination with phentermine as part of Fen-Phen, an anti-obesity medication. Fenfluramine was withdrawn from the US market in 1997 due to reports of heart valvular disease, pulmonary arterial hypertension, and cardiac fibrosis. Particularly, idiopathic...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Weijuan, Mu, Wenbo, Zeifman, Amy, Lofti, Michelle, Remillard, Carmelle V., Makino, Ayako, Perkins, David L., Garcia, Joe G., Yuan, Jason X. J., Zhang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224433/
https://www.ncbi.nlm.nih.gov/pubmed/22140631
http://dx.doi.org/10.4103/2045-8932.87310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224433/
https://www.ncbi.nlm.nih.gov/pubmed/22140631
http://dx.doi.org/10.4103/2045-8932.87310

Ejemplares similares